-study. Of all eligible participants, 224 (56.7%) participated in the BeatAML sub-study. The remaining 171 patients were classified as standard care (SOC) (103), research therapy (28) or palliative care (40);
Tengshengbo Pharmaceuticals and VBI Vaccines said positive data were available in the middle of the CHB immunotherapy 1b/2a trial
Time of Update: 2021-02-24
interim data showed that in the study group of low-dose BRII-179 (VBI-2601) combined/non-joint adulations, 67% (n-6/9) and 78% (n-7/9) of assessable patient T-cells had an effect on the re-stimulation of HBV surface antigens.
Pfizer's submission of the latest stability data for the new crown vaccine is expected to increase storage/shipping flexibility
Time of Update: 2021-02-24
to the FDA includes stability data for different batches produced during the development of the new crown vaccine over the past nine months.
BMJ | Relax! Data for 440,000 people in Asia: HPV vaccine safety report
Time of Update: 2021-02-24
, a national queue study from South Korea assessed the link between HPV vaccination and adverse events among 440,000 Adolescent Girls in Asia, adding important evidence to the safety of HPV vaccines for Asian populations.
Gilead published clinical data on GS-9688, a new functional drug for hepatitis B
Time of Update: 2021-02-24
recently, Gilead, the US pharmaceutical giant, released new clinical data on , a functional cure for hepatitis B. About GS-9688 GS-9688 is an oral, selective tooll-like subject 8 (TLR8) small molecular
Lancet sub-issue: Shock! 170 million consultation data reveal the unreasonable status quo of antibiotic use in China!
Time of Update: 2021-02-24
, according to the latest research data from the Chinese Academy of Sciences, the daily use of antibiotics per 1,000 people in China is 5.7 times that of the United Kingdom and 5.5 times that of the United States.
Comparative Genomics: Digging for Data
Time of Update: 2021-02-24
With more and more genome sequences becoming available, the rise of comparative genomics continues apace.
Chen Wei team's vaccine release phase three data experts: suitable for rapid mass vaccination
Time of Update: 2021-02-24
Pharma.com, Feb. 9 (Xinhua) -- Following the release of phase III clinical data on two inactivated vaccines from China Bio and Koxing Zhongwei, another technical route for the deployment of China's new crown vaccine, the latest data on Ad5-nCoV
JNNP: Neonatal-youth data for the treatment of type 1 spinal muscular dystrophy with sodium Nosine - 1 year data from three Asia Pacific regions
Time of Update: 2021-02-23
, only 6.7 percent (1/15 patients) of patients over 2 years of age who started sodium nossinasitic therapy achieved an unassaless sitting position.
Data science research has found five key genes and seven subsypes of the new crown
Time of Update: 2021-02-23
Recently, researchers analyzed systematic gene interactions between two sets of gene expression data based on plasma and white blood cell sampling, published in Cell-System, and found that five key genes not only completely determine whether
Antibody cocktail therapy TATX-03 PolyTope treats COVID-19, preclinical data show 100% effective
Time of Update: 2021-02-23
TATX-03 PolyTope antibody cocktail therapy was given in a single dose to hamsters infected with the SARS-CoV-2 variant.
Alzheimer's Dementia: Data on 60 million people in the United States has found that the risk of new
Time of Update: 2021-02-23
severe symptoms caused by COVID-19 occur mainly in the elderly and individuals with underlying clinical conditions, such as Alzheimer's disease (AD), which is a common cause of morbidity and death in older populations.
Breast cancer HER2 target re-explosion of new drug data more than 80% efficiency
Time of Update: 2021-02-22
good results, let's look at it together. DS8201, a her2 antibody-elixir chemotherapy drug, belongs to the ADC type of drug (antibody concedes). It consists of two parts: the first is antibodies against HER2 targets, which